Royal Bank of Canada’s PhenomeX Inc. Common Stock CELL Stock Holding History

Royal Bank of Canada’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-33,300	Closed	-$1.49M	–	7981
2021 Q2	$1.49M	Buy	+33,300	New	+$1.54M	﹤0.01%	3314

Royal Bank of Canada's CELL Position: Q4 2023 in Review

Royal Bank of Canada sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 383 shares.

Royal Bank of Canada first reported a position in CELL in Q3 2020 and held it in 13 quarters. The position peaked at $2.22M in Q2 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

Royal Bank of Canada reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Royal Bank of Canada sold 383 PhenomeX Inc. Common Stock shares in Q4 2023.
Royal Bank of Canada first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 13 quarters.
Royal Bank of Canada's PhenomeX Inc. Common Stock position peaked at $2.22M in Q2 2021.
0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.